AAAAAA

   
Results: 1-7 |
Results: 7

Authors: LANGREHR JM GLANEMANN M GUCKELBERGER O KLUPP J NEUMANN U MACHENS C LOHMANN R KNOOP M LOBECK H SCHLAG H KECK H SETTMACHER U BECHSTEIN WO NEUHAUS PJ
Citation: Jm. Langrehr et al., A RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY FOR IMMUNOSUPPRESSIVE INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION, Clinical transplantation, 12(4), 1998, pp. 303-312

Authors: GLANEMANN M LANGREHR JM RAAKOW R GUCKELBERGER O LOHMANN R KLUPP J LOBECK H SCHLAG H KECK H BECHSTEIN WO SETTMACHER U NEUHAUS P
Citation: M. Glanemann et al., ANTI-IL-2 RECEPTOR BT563 VERSUS PLACEBO - A RANDOMIZED TRIAL FOR INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 30(5), 1998, pp. 2159-2160

Authors: LANGREHR JM GLANEMANN M SCHNELLER A NEUMANN U GUCKELBERGER O LOHMANN R KLUPP J JONAS S KNOOP M LOBECK H SCHLAG H KECK H SETTMACHER U BECHSTEIN WO NEUHAUS PJ
Citation: Jm. Langrehr et al., A RANDOMIZED TRIAL COMPARING ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY ANDPLACEBO FOR IMMUNOSUPPRESSIVE THERAPY AFTER OLT, Transplantation proceedings, 30(4), 1998, pp. 1445-1446

Authors: LANGREHR JM NUSSLER NC NEUMANN U GUCKELBERGER O LOHMANN R RADTKE A JONAS S KLUPP J STEINMULLER T LOBECK H MEUER S SCHLAG H LEMMENS HP KNOOP M KECK H BECHSTEIN WO NEUHAUS P
Citation: Jm. Langrehr et al., A PROSPECTIVE RANDOMIZED TRIAL COMPARING INTERLEUKIN-8 RECEPTOR ANTIBODY VERSUS ANTITHYMOCYTE GLOBULIN AS PART OF A QUADRUPLE IMMUNOSUPPRESSIVE INDUCTION THERAPY FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION, Transplantation, 63(12), 1997, pp. 1772-1781

Authors: LEIMENSTOLL G ENGEMANN R GASSEL J HOFFMANN S PREUSSE D SCHLAG H NIEDERMAYER W
Citation: G. Leimenstoll et al., CYTOKINE SECRETION CAPACITY OF MONONUCLEAR-CELLS IN RENAL-TRANSPLANT RECIPIENTS - THE EFFECT OF 2 DIFFERENT DOSE SCHEDULES, Transplantation proceedings, 25(4), 1993, pp. 2666-2668

Authors: NEUHAUS P BECHSTEIN WO BLUMHARDT G STEFFEN R KECK H LEMMENS P LANGREHR JM SCHLAG H
Citation: P. Neuhaus et al., QUADRUPLE INDUCTION IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATION WITH INTERLEUKIN-2 RECEPTOR ANTIBODY (BT 563) IS EQUALLY EFFECTIVE AND BETTER TOLERATED THAN ANTITHYMOCYTE GLOBULIN INDUCTION THERAPY, Transplantation proceedings, 25(2), 1993, pp. 1940-1941

Authors: NEUHAUS P BECHSTEIN WO BLUMHARDT G WIENS M LEMMENS P LANGREHR JM LOHMANN R STEFFEN R SCHLAG H SLAMA KJ LOBECK H
Citation: P. Neuhaus et al., COMPARISON OF QUADRUPLE IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATIONWITH ATG OR IL-2 RECEPTOR ANTIBODY, Transplantation, 55(6), 1993, pp. 1320-1327
Risultati: 1-7 |